Korstanje C, van Zwieten P A
Division of Pharmacotherapy, University of Amsterdam, The Netherlands.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):409-14. doi: 10.1007/BF00164874.
The effects of phenoxybenzamine and benextramine were assessed with respect to the vasoconstriction to cirazoline in rat perfused hindquarters. Experiments were performed with and without restriction of inward calcium flux by addition of nifedipine (10(-9)-10(-6) M) to the standard physiological solution (PS), or by omission of calcium chloride from the PS. Addition of nifedipine or omission of Ca2+ did not affect the maximal response or potency of the selective but partial alpha 1-adrenoceptor agonist, cirazoline in rat perfused hindquarters. Upon pretreatment with phenoxybenzamine (0.03-30 micrograms/kg, i.v. at -1 h) or benextramine (1 mg/kg, i.v. at -2 h) both the slope and the maximal response to cirazoline were depressed. After phenoxybenzamine but not after benextramine the maximal response to cirazoline was depressed further upon addition of nifedipine or omission of Ca2+ from the PS. It is concluded that phenoxybenzamine selectively inhibits that part of the alpha 1-adrenoceptor mediated vasoconstriction that is independent of extracellular calcium, thereby unmasking a calcium-entry sensitive mechanism of vasoconstriction to cirazoline.
就大鼠灌注后肢对可乐定的血管收缩作用而言,评估了酚苄明和苯苄胺的效果。实验分别在标准生理溶液(PS)中添加硝苯地平(10⁻⁹ - 10⁻⁶ M)或从PS中省略氯化钙来限制内向钙通量的情况下进行,以及不进行这种限制的情况下进行。添加硝苯地平或省略Ca²⁺ 并不影响选择性但部分激动的α₁ - 肾上腺素能受体激动剂可乐定在大鼠灌注后肢中的最大反应或效能。在用酚苄明(0.03 - 30微克/千克,静脉注射,于 -1小时)或苯苄胺(1毫克/千克,静脉注射,于 -2小时)预处理后,对可乐定的斜率和最大反应均降低。在酚苄明预处理后,而不是在苯苄胺预处理后,当从PS中添加硝苯地平或省略Ca²⁺ 时,对可乐定的最大反应进一步降低。结论是,酚苄明选择性抑制α₁ - 肾上腺素能受体介导的与细胞外钙无关的那部分血管收缩作用,从而揭示了对可乐定血管收缩的钙内流敏感机制。